These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31056860)

  • 41. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
    Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
    BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.
    Mantovani V; Bin S; Graziano C; Capelli I; Minardi R; Aiello V; Ambrosini E; Cristalli CP; Mattiaccio A; Pariali M; De Fanti S; Faletra F; Grosso E; Cantone R; Mancini E; Mencarelli F; Pasini A; Wischmeijer A; Sciascia N; Seri M; La Manna G
    Front Genet; 2020; 11():464. PubMed ID: 32457805
    [No Abstract]   [Full Text] [Related]  

  • 43. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of targeted next-generation sequencing in children with cystic kidney diseases often change the clinical diagnosis.
    Obeidova L; Seeman T; Fencl F; Blahova K; Hojny J; Elisakova V; Reiterova J; Stekrova J
    PLoS One; 2020; 15(6):e0235071. PubMed ID: 32574212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
    Hopp K; Cornec-Le Gall E; Senum SR; Te Paske IBAW; Raj S; Lavu S; Baheti S; Edwards ME; Madsen CD; Heyer CM; Ong ACM; Bae KT; Fatica R; Steinman TI; Chapman AB; Gitomer B; Perrone RD; Rahbari-Oskoui FF; Torres VE; ; Harris PC
    Kidney Int; 2020 Feb; 97(2):370-382. PubMed ID: 31874800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
    Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
    Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational screening of PKD2 gene in the north Indian polycystic kidney disease patients revealed 28 genetic variations.
    Raj S; Singh RG; Das P
    J Genet; 2017 Dec; 96(6):885-893. PubMed ID: 29321346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic Kidney Disease without an Apparent Family History.
    Iliuta IA; Kalatharan V; Wang K; Cornec-Le Gall E; Conklin J; Pourafkari M; Ting R; Chen C; Borgo AC; He N; Song X; Heyer CM; Senum SR; Hwang YH; Paterson AD; Harris PC; Khalili K; Pei Y
    J Am Soc Nephrol; 2017 Sep; 28(9):2768-2776. PubMed ID: 28522688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes.
    Neumann HP; Bacher J; Nabulsi Z; Ortiz Brüchle N; Hoffmann MM; Schaeffner E; Nürnberger J; Cybulla M; Wilpert J; Riegler P; Corradini R; Kraemer-Guth A; Azurmendi P; Nunez M; Gläsker S; Zerres K; Jilg C
    Int Urol Nephrol; 2012 Dec; 44(6):1753-62. PubMed ID: 22367170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease.
    O'Brien K; Font-Montgomery E; Lukose L; Bryant J; Piwnica-Worms K; Edwards H; Riney L; Garcia A; Daryanani K; Choyke P; Mohan P; Heller T; Gahl WA; Gunay-Aygun M
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):83-9. PubMed ID: 21694639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
    Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
    Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of mutations in six Chinese families with autosomal dominant polycystic kidney disease.
    Wang H; Dai S; Zhang J; Li Y; Gan Y; Lu T; Zhu Y; Wu J; Lin N; Tang F; Luo J
    Am J Transl Res; 2020; 12(12):8123-8136. PubMed ID: 33437386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease.
    Bitarafan F; Garshasbi M
    J Res Med Sci; 2019; 24():44. PubMed ID: 31160911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.
    Tan YC; Blumenfeld JD; Anghel R; Donahue S; Belenkaya R; Balina M; Parker T; Levine D; Leonard DG; Rennert H
    Hum Mutat; 2009 Feb; 30(2):264-73. PubMed ID: 18837007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation.
    Zacchia M; Blanco FDV; Trepiccione F; Blasio G; Torella A; Melluso A; Capolongo G; Pollastro RM; Piluso G; Di Iorio V; Simonelli F; Viggiano D; Perna A; Nigro V; Capasso G
    J Nephrol; 2021 Dec; 34(6):1855-1874. PubMed ID: 33964006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.
    Pei Y; Paterson AD; Wang KR; He N; Hefferton D; Watnick T; Germino GG; Parfrey P; Somlo S; St George-Hyslop P
    Am J Hum Genet; 2001 Feb; 68(2):355-63. PubMed ID: 11156533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two novel mutations affecting the same splice site of PKD1 correlate with different phenotypes in ADPKD.
    Yu C; Li J; Yuan Z; Liu S; Zou L
    Ren Fail; 2014 Jun; 36(5):687-93. PubMed ID: 24575920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing.
    Trujillano D; Bullich G; Ossowski S; Ballarín J; Torra R; Estivill X; Ars E
    Mol Genet Genomic Med; 2014 Sep; 2(5):412-21. PubMed ID: 25333066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes.
    Yang H; Sieben CJ; Schauer RS; Harris PC
    Adv Kidney Dis Health; 2023 Sep; 30(5):397-406. PubMed ID: 38097330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.